basal cell carcinoma |
Disease ID | 245 |
---|---|
Disease | basal cell carcinoma |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:25) HP:0002664 | Neoplasia | 13 HP:0003764 | Naevus | 6 HP:0002671 | Basalioma | 4 HP:0002861 | Melanoma | 3 HP:0010603 | Keratocystic odontogenic tumor | 3 HP:0100612 | Odontogenic neoplasm | 3 HP:0002860 | Squamous cell carcinoma | 2 HP:0000656 | Ectropion | 1 HP:0012636 | Retinal vein occlusion | 1 HP:0000083 | Renal insufficiency | 1 HP:0001052 | port-wine stain | 1 HP:0000924 | Abnormality of the skeletal system | 1 HP:0010612 | Plantar pits | 1 HP:0010610 | Palmar pits | 1 HP:0003774 | End-stage renal failure | 1 HP:0200040 | Epidermal inclusion cyst | 1 HP:0001274 | Absent corpus callosum | 1 HP:0012089 | Arteritis | 1 HP:0012844 | Trichilemmoma | 1 HP:0001025 | Hives | 1 HP:0001022 | Achromasia | 1 HP:0030447 | Cutaneous APUDoma | 1 HP:0001045 | Blotchy loss of skin color | 1 HP:0000718 | Aggressive behaviour | 1 HP:0002858 | Mengiomia | 1 |
Disease ID | 245 |
---|---|
Disease | basal cell carcinoma |
Manually Symptom | UMLS | Name(Total Manually Symptoms:17) C0796561 | melanoma C0684550 | spinal metastases C0334041 | osteoma cutis C0268948 | scrotal ulcer C0268397 | cutaneous amyloidosis C0268392 | localized amyloidosis C0239495 | granuloma faciale C0238790 | bone destruction C0220654 | meningeal carcinomatosis C0162839 | porokeratosis C0153690 | bone metastasis C0153676 | pulmonary metastasis C0037284 | skin lesions C0027030 | myiasis C0024232 | lymphatic metastasis C0022603 | seborrhoeic keratosis C0002171 | alopecia areata |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:5) C0025202 | melanoma | 3 C0027030 | myiasis | 1 C0153676 | pulmonary metastasis | 1 C0153690 | bone metastasis | 1 C0037284 | skin lesions | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:24) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs11170164 | 25855136 | 3852 | KRT5 | umls:C0007117 | GWASCAT | New basal cell carcinoma susceptibility loci. | 0.242367032 | 2015 | KRT5 | 12 | 52519884 | C | T |
rs12210050 | 21700618 | 3662 | IRF4 | umls:C0007117 | GAD | [Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma.] | 0.002367032 | 2011 | LOC105374875 | 6 | 475489 | C | T |
rs13014235 | 25855136 | 130540 | ALS2CR12 | umls:C0007117 | GWASCAT | Here we show the discovery of four new BCC susceptibility loci: 2p24 MYCN (rs57244888[C], OR=0.76, P=4.7 × 10(-12)), 2q33 CASP8-ALS2CR12 (rs13014235[C], OR=1.15, P=1.5 × 10(-9)), 8q21 ZFHX4 (rs28727938[G], OR=0.70, P=3.5 × 10(-12)) and 10p14 GATA3 (rs73635312[A], OR=0.74, P=2.4 × 10(-16)). | 0.12 | 2015 | ALS2CR12 | 2 | 201350769 | C | G |
rs157935 | 25855136 | 378805 | LINC-PINT | umls:C0007117 | GWASCAT | New basal cell carcinoma susceptibility loci. | 0.12 | 2015 | LINC-PINT | 7 | 130900794 | T | G |
rs157935 | 24403052 | 378805 | LINC-PINT | umls:C0007117 | GWASCAT | Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma. | 0.12 | 2015 | LINC-PINT | 7 | 130900794 | T | G |
rs1805007 | 21700618 | 4157 | MC1R | umls:C0007117 | GAD | [A non-synonymous SNP in the MC1R gene (rs1805007 encoding Arg151Cys substitution), a previously well-documented pigmentation gene, showed the strongest association with BCC risk in the discovery set (rs1805007T: OR (95% CI) for combined discovery set and replication set 1.55 (1.45-1.66); P= 4.3 A 10(-17).] | 0.25728386 | 2011 | MC1R | 16 | 89919709 | C | G,T |
rs1805007 | 21700618 | 4157 | MC1R | umls:C0007117 | GWASCAT | A non-synonymous SNP in the MC1R gene (rs1805007 encoding Arg151Cys substitution), a previously well-documented pigmentation gene, showed the strongest association with BCC risk in the discovery set (rs1805007[T]: OR (95% CI) for combined discovery set and replication set [1.55 (1.45-1.66); P= 4.3 × 10(-17)]. | 0.25728386 | 2011 | MC1R | 16 | 89919709 | C | G,T |
rs214782 | 25855136 | 7053 | TGM3 | umls:C0007117 | GWASCAT | New basal cell carcinoma susceptibility loci. | 0.12 | 2015 | TGM3;LOC105372503 | 20 | 2301324 | G | A |
rs214782 | 24403052 | 7053 | TGM3 | umls:C0007117 | GWASCAT | Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma. | 0.12 | 2015 | TGM3;LOC105372503 | 20 | 2301324 | G | A |
rs2151280 | 24403052 | 100048912 | CDKN2B-AS1 | umls:C0007117 | GWASCAT | Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma. | 0.12 | 2015 | CDKN2B-AS1 | 9 | 22034720 | G | A |
rs2151280 | 25855136 | 100048912 | CDKN2B-AS1 | umls:C0007117 | GWASCAT | New basal cell carcinoma susceptibility loci. | 0.12 | 2015 | CDKN2B-AS1 | 9 | 22034720 | G | A |
rs401681 | 25855136 | 81037 | CLPTM1L | umls:C0007117 | GWASCAT | New basal cell carcinoma susceptibility loci. | 0.242367032 | 2015 | CLPTM1L | 5 | 1321972 | C | T |
rs401681 | 19151717 | 81037 | CLPTM1L | umls:C0007117 | GWASCAT | Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. | 0.242367032 | 2009 | CLPTM1L | 5 | 1321972 | C | T |
rs401681 | 24403052 | 81037 | CLPTM1L | umls:C0007117 | GWASCAT | Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma. | 0.242367032 | 2015 | CLPTM1L | 5 | 1321972 | C | T |
rs7006527 | 24403052 | 26166 | RGS22 | umls:C0007117 | GWASCAT | Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma. | 0.12 | 2015 | RGS22 | 8 | 100012277 | A | C |
rs7006527 | 25855136 | 26166 | RGS22 | umls:C0007117 | GWASCAT | New basal cell carcinoma susceptibility loci. | 0.12 | 2015 | RGS22 | 8 | 100012277 | A | C |
rs7538876 | 18849993 | 353238 | PADI6 | umls:C0007117 | GWASCAT | Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits. | 0.122367032 | 2008 | PADI6 | 1 | 17395867 | G | A |
rs7538876 | 24403052 | 353238 | PADI6 | umls:C0007117 | GWASCAT | Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma. | 0.122367032 | 2015 | PADI6 | 1 | 17395867 | G | A |
rs7538876 | 18849993 | 353238 | PADI6 | umls:C0007117 | GAD | [Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits.] | 0.122367032 | 2008 | PADI6 | 1 | 17395867 | G | A |
rs7538876 | 25855136 | 353238 | PADI6 | umls:C0007117 | GWASCAT | New basal cell carcinoma susceptibility loci. | 0.122367032 | 2015 | PADI6 | 1 | 17395867 | G | A |
rs78378222 | 24403052 | 7157 | TP53 | umls:C0007117 | GWASCAT | Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma. | 0.255274147 | 2015 | TP53 | 17 | 7668434 | T | G |
rs78378222 | 21946351 | 7157 | TP53 | umls:C0007117 | GWASCAT | A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. | 0.255274147 | 2011 | TP53 | 17 | 7668434 | T | G |
rs78378222 | 25855136 | 7157 | TP53 | umls:C0007117 | GWASCAT | New basal cell carcinoma susceptibility loci. | 0.255274147 | 2015 | TP53 | 17 | 7668434 | T | G |
rs801114 | 18849993 | 58480 | RHOU | umls:C0007117 | GAD | [Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits.] | 0.002367032 | 2008 | NA | 1 | 228862088 | T | G |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:35) | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHR | POS | SNPID | REF | ALT | ORI_SNPID | PMID | P_VALUE | P_VALUE_TEXT | OR/BETA | CI95_TEXT | GWAS_INITIAL_SAMPLE_SIZE | SUB_POPULATION | SUPER_POPULATION | GWAS_TRAIT | HPO_ID | HPO_TERM | DO_ID | DO_TERM | MESH_ID | MESH_TERM | EFO_ID | EFO_TERM | DOLITE_TERM | RISK_ALLELE | PUBLICATION_TYPE | AA | GENE_SYMBOL | TYPE | REFGENE |
1 | 17722363 | rs7538876 | G | A | rs7538876 | 18849993 | 4.00E-12 | NA | 1.28 | [1.19-1.37] | 930 cases; 33,117 controls | NOPOP(34047) | ALL(34047) | NOPOP(34047) | ALL(34047) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs7538876-A | NA | A | PADI6 |
1 | 17722363 | rs7538876 | G | A | rs7538876 | 24403052 | 7.00E-14 | NA | 1.25 | [1.18-1.32] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs7538876-A | Research Support, Non-U.S. Gov't | A | PADI6 |
1 | 228997835 | rs801114 | T | G | rs801114 | 18849993 | 6.00E-12 | NA | 1.28 | [1.19-1.37] | 930 cases; 33,117 controls | NOPOP(34047) | ALL(34047) | NOPOP(34047) | ALL(34047) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs801114-G | NA | G | NA |
1 | 228997835 | rs801114 | T | G | rs801114 | 24403052 | 2.00E-13 | NA | 1.25 | [1.17-1.32] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs801114-G | Research Support, Non-U.S. Gov't | G | NA |
3 | 104590454 | rs9826514 | C | T | rs9826514 | 21700618 | 7.20E-05 | NA | NA | NA | 2,045 European ancestry cases; 6,013 European ancestry controls | European(8058) | ALL(8058) | EUR(8058) | ALL(8058) | basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | NA | Research Support, N.I.H., Extramural | C | NA |
3 | 104599330 | rs11926023 | T | C | rs11926023 | 21700618 | 4.60E-05 | NA | NA | NA | 2,045 European ancestry cases; 6,013 European ancestry controls | European(8058) | ALL(8058) | EUR(8058) | ALL(8058) | basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | NA | Research Support, N.I.H., Extramural | T | NA |
3 | 171558344 | rs6794092 | G | A | rs6794092 | 21700618 | 2.00E-06 | NA | 0.17 | [0.10-0.24] unit increase | 2,045 European ancestry cases; 6,013 European ancestry controls | European(8058) | ALL(8058) | EUR(8058) | ALL(8058) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs6794092-G | Research Support, N.I.H., Extramural | G | NA |
5 | 1322087 | rs401681 | C | T | rs401681 | 19151717 | 4.00E-12 | Basal cell carcinoma | NA | NA | 2565 cases; 29405 controls | NOPOP(31970) | ALL(31970) | NOPOP(31970) | ALL(31970) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Comparative Study |
5 | 1322087 | rs401681 | C | T | rs401681 | 24403052 | 2.00E-12 | NA | 1.23 | [1.16-1.30] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs401681-C | Research Support, Non-U.S. Gov't | T | CLPTM1L |
5 | 153509596 | rs2033195 | T | C | rs2033195 | 21700618 | 6.00E-06 | NA | 0.09 | [0.05-0.13] unit increase | 2,045 European ancestry cases; 6,013 European ancestry controls | European(8058) | ALL(8058) | EUR(8058) | ALL(8058) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs2033195-C | Research Support, N.I.H., Extramural | C | NA |
6 | 471136 | rs12202284 | C | A | rs12202284 | 21700618 | 6.30E-07 | NA | NA | NA | 2,045 European ancestry cases; 6,013 European ancestry controls | European(8058) | ALL(8058) | EUR(8058) | ALL(8058) | basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | NA | Research Support, N.I.H., Extramural | C | NA |
6 | 475489 | rs12210050 | C | T | rs12210050 | 21700618 | 1.00E-09 | NA | 1.24 | [1.17-1.31] | 2,045 European ancestry cases; 6,013 European ancestry controls | European(8058) | ALL(8058) | EUR(8058) | ALL(8058) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs12210050-T | Research Support, N.I.H., Extramural | C | NA |
7 | 130585553 | rs157935 | T | G | rs157935 | 24403052 | 9.00E-11 | NA | 1.23 | [1.15-1.31] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs157935-T | Research Support, Non-U.S. Gov't | G | LOC646329 |
8 | 101024505 | rs7006527 | A | C | rs7006527 | 24403052 | 9.00E-10 | NA | 1.3 | [1.20-1.43] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | NA | Research Support, Non-U.S. Gov't | A | RGS22 |
8 | 101024505 | rs7006527 | A | C | rs7006527 | 24403052 | 9.00E-13 | NA | 1.3 | [1.22-1.41] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | NA | Research Support, Non-U.S. Gov't | A | RGS22 |
8 | 101096089 | rs113394050 | T | C | rs113394050 | 24403052 | 7.38E-04 | NA | NA | NA | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs113394050-C | Research Support, Non-U.S. Gov't | T | RGS22 |
9 | 22034719 | rs2151280 | G | A | rs2151280 | 24403052 | 3.00E-10 | NA | 1.2 | [1.14-1.27] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs2151280-G | Research Support, Non-U.S. Gov't | C | CDKN2B-AS1 |
12 | 52913668 | rs11170164 | C | T | rs11170164 | 24403052 | 3.00E-06 | NA | 1.25 | [1.14-1.37] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs11170164-T | Research Support, Non-U.S. Gov't | G | KRT5 |
13 | 99968151 | rs9517683 | A | G | rs9517683 | 21700618 | 2.30E-05 | NA | NA | NA | 2,045 European ancestry cases; 6,013 European ancestry controls | European(8058) | ALL(8058) | EUR(8058) | ALL(8058) | basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | NA | Research Support, N.I.H., Extramural | A | UBAC2 |
13 | 100041738 | rs7335046 | G | C | rs7335046 | 21700618 | 3.00E-08 | NA | 1.26 | [1.18-1.34] | 2,045 European ancestry cases; 6,013 European ancestry controls | European(8058) | ALL(8058) | EUR(8058) | ALL(8058) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs7335046-G | Research Support, N.I.H., Extramural | G | NA |
16 | 89986117 | rs1805007 | C | T | rs1805007 | 21700618 | 4.00E-17 | NA | 1.55 | [1.45-1.66] | 2,045 European ancestry cases; 6,013 European ancestry controls | European(8058) | ALL(8058) | EUR(8058) | ALL(8058) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs1805007-T | Research Support, N.I.H., Extramural | C | MC1R |
17 | 7571752 | rs78378222 | T | G | rs78378222 | 21946351 | 1.00E-05 | Glioma | NA | NA | 2121 Icelandic cases; 39614 Icelandic controls | Icelandic(41735) | ALL(41735) | EUR(41735) | ALL(41735) | Skin cancer (cutaneous basal cell carcinoma) | HPOID:0002671 | Basal cell carcinoma | DOID:4282 | pigmented basal cell carcinoma | NA | NA | NA | NA | Basal cell carcinoma | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, American Recovery and Reinvestment Act |
17 | 7571752 | rs78378222 | T | G | rs78378222 | 21946351 | 1.60E-04 | Colorectal cancer | NA | NA | 2121 Icelandic cases; 39614 Icelandic controls | Icelandic(41735) | ALL(41735) | EUR(41735) | ALL(41735) | Skin cancer (cutaneous basal cell carcinoma) | HPOID:0002671 | Basal cell carcinoma | DOID:4282 | pigmented basal cell carcinoma | NA | NA | NA | NA | Basal cell carcinoma | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, American Recovery and Reinvestment Act |
17 | 7571752 | rs78378222 | T | G | rs78378222 | 21946351 | 2.20E-20 | Cutaneous squamous cell carcinoma (skin cancer) | NA | NA | 2121 Icelandic cases; 39614 Icelandic controls | Icelandic(41735) | ALL(41735) | EUR(41735) | ALL(41735) | Skin cancer (cutaneous basal cell carcinoma) | HPOID:0002671 | Basal cell carcinoma | DOID:4282 | pigmented basal cell carcinoma | NA | NA | NA | NA | Basal cell carcinoma | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, American Recovery and Reinvestment Act |
17 | 7571752 | rs78378222 | T | G | rs78378222 | 21946351 | 2.40E-06 | Prostate cancer | NA | NA | 2121 Icelandic cases; 39614 Icelandic controls | Icelandic(41735) | ALL(41735) | EUR(41735) | ALL(41735) | Skin cancer (cutaneous basal cell carcinoma) | HPOID:0002671 | Basal cell carcinoma | DOID:4282 | pigmented basal cell carcinoma | NA | NA | NA | NA | Basal cell carcinoma | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, American Recovery and Reinvestment Act |
17 | 7571752 | rs78378222 | T | G | rs78378222 | 24403052 | 4.00E-22 | NA | 2.24 | [1.90-2.64] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs78378222-G | Research Support, Non-U.S. Gov't | A | TP53 |
20 | 2220310 | rs59586681 | A | T | rs59586681 | 24403052 | 3.00E-09 | NA | 1.16 | [1.11-1.22] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs59586681-T | Research Support, Non-U.S. Gov't | A | NA |
20 | 2262537 | rs6082600 | T | C | rs6082600 | 24403052 | 1.10E-04 | NA | NA | NA | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs6082600-C | Research Support, Non-U.S. Gov't | T | NA |
20 | 2270015 | rs214748 | C | T | rs214748 | 24403052 | 9.10E-04 | NA | NA | NA | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs214748-C | Research Support, Non-U.S. Gov't | C | NA |
20 | 2273987 | rs214755 | A | T | rs214755 | 24403052 | 8.20E-04 | NA | NA | NA | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs214755-A | Research Support, Non-U.S. Gov't | A | NA |
20 | 2279435 | rs214770 | A | G | rs214770 | 24403052 | 6.20E-04 | NA | NA | NA | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs214770-A | Research Support, Non-U.S. Gov't | A | TGM3 |
20 | 2281970 | rs214782 | G | A | rs214782 | 24403052 | 6.00E-17 | NA | 1.29 | [1.22-1.37] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs214782-G | Research Support, Non-U.S. Gov't | G | TGM3 |
20 | 2288590 | rs214801 | G | A | rs214801 | 24403052 | 2.50E-04 | NA | NA | NA | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs214801-G | Research Support, Non-U.S. Gov't | G | TGM3 |
20 | 2290333 | rs214803 | C | A | rs214803 | 24403052 | 5.00E-16 | NA | 1.28 | [1.21-1.37] | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs214803-G | Research Support, Non-U.S. Gov't | G | TGM3 |
20 | 2292273 | rs214807 | G | A | rs214807 | 24403052 | 1.10E-04 | NA | NA | NA | 4,208 European ancestry cases; 109,408 European ancestry controls | European(113616) | ALL(113616) | EUR(113616) | ALL(113616) | Basal cell carcinoma | HPOID:0002671 | Basal cell carcinoma | DOID:2513 | basal cell carcinoma | NA | NA | EFOID:0004193 | basal cell carcinoma | Basal cell carcinoma | rs214807-G | Research Support, Non-U.S. Gov't | C | TGM3 |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:1) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0007117 | methotrexate | D008727 | 1959/5/2 | carcinoma, basal cell | MESH:D002280 | therapeutic | 4058741 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |